|
Volumn 202, Issue 3, 2002, Pages 148-151
|
Toxoplasmosis after antineoplastic therapy in non-Hodgkin lymphoma. Demand of preventive measures
a a a |
Author keywords
Bone marrow transplantation; Lymphoma; Prophylaxis; Toxoplasmosis
|
Indexed keywords
AMIKACIN;
AMPHOTERICIN B LIPID COMPLEX;
ANTINEOPLASTIC AGENT;
CARMUSTINE;
CLINDAMYCIN;
COLONY STIMULATING FACTOR;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
IMMUNOGLOBULIN G;
MEROPENEM;
PREDNISONE;
PYRIMETHAMINE;
SULFONAMIDE;
VANCOMYCIN;
VINCRISTINE;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
CASE REPORT;
CHOROIDITIS;
CLINICAL FEATURE;
DRUG RESPONSE;
FEBRILE NEUTROPENIA;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNE DEFICIENCY;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
MORBIDITY;
MORTALITY;
NONHODGKIN LYMPHOMA;
OPPORTUNISTIC INFECTION;
PREOPERATIVE EVALUATION;
RECIPIENT;
RISK ASSESSMENT;
SEROLOGY;
TOXOPLASMA;
TOXOPLASMOSIS;
|
EID: 0036316118
PISSN: 00142565
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2565(02)71010-2 Document Type: Article |
Times cited : (2)
|
References (19)
|